bpac home
Search  Publication   Category 

Antipsychotics in dementia: Best Practice Guide

 Introduction, Rationale and Key Points 
 Behavioural and Psychological Symptoms of Dementia (BPSD) 
 Assessment of patients with BPSD 
 Non-pharmacological treatment of BPSD 
 Pharmacological treatment of BPSD 
 Adverse effects of antipsychotics 
 Dementia with Lewy Bodies (DLB) 
 Other medicines for BPSD 
 Treatment of comorbid conditions in patients with dementia 
 References 
 Appendix 
  Click here for a PDF

Appendix: Best practice prescribing of antipsychotics for elders in residential care (algorithm)

These recommendations represent the expert opinion and evidence-based knowledge of the RANZCP Faculty of Psychiatry of Old Age (New Zealand). Published clinical trial evidence relating to this area of prescribing is sometimes sparse, preliminary or even non-existent in respect of many of the issues covered. Pooled clinical expertise, relevant international guidelines and peer-reviewed research literature have been critical to developing these recommendations. The algorithm below summarises these recommendations.

 
Work on developing a shared culture of care that supports best-practice antipsychotic prescribing.
 
   
 
Identify the target problem.
Record intensity, frequency and consequences.
 
   
 
Set a realistic treatment aim
 
   
Formulate the target problem
Manage any contributing medical or psychiatric conditions
Initiate non-pharmacological management
  • specific
  • general
Continue in parallel with any pharmacological treatment.
Decide whether or not to trial an antipsychotic:
  • Is the target problem likely to respond?
  • Is the acuity high enough (in terms of suffering and risk)?
  • Do the likely benefits outweigh the risks?
  • Is non-pharmacological management effective on its own?
 
 
Initiate an antipsychotic trial:
  • Choose an appropriate antipsychotic based on the person’s side effect risk profile
  • Decide on the target dose and length of trial
  • Educate staff on side effects of concern
  • Decide on a monitoring plan
 
 
Gain appropriate consent given the circumstances
 
 
Titrate medicine up to target does for length of treatment trial unless side effects or effectiveness occur earlier
 
 
Formally evaluate the trialled management
 
   
Continue the medication and non-pharmacological approaches with regular review and consideration of dose adjustment and cessation     Carefully withdraw treatment and reconsider the problem and its management

Page  1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 Page 11

Submit a comment about this article